Andrew Savidge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Andrew Savidge has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Kotaro Nakanishi
Department of Chemistry and Biochemistry, The Ohio State University
4 shared publications - Zhangfei Shen
Department of Biological Chemistry and Pharmacology, The Ohio State University
3 shared publications Adhav V
2 shared publications- Audrey C. Kehling
Department of Chemistry and Biochemistry, The Ohio State University
2 shared publications Fu T
2 shared publications- GeunYoung Sim
Center for RNA Biology, The Ohio State University
2 shared publications
Latest Publications
- Open Access
- 10 August 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (33)
Central guide–target pairing activates human Argonaute2 by uncoupling the N-PAZ and MID–PIWI lobes
Small interfering RNAs (siRNAs) are widely used to repress gene expression. For human Argonaute2 (AGO2) to cleave target RNA, siRNAs must be almost perfectly complementary to their targets, particularly in the central region, yet the mechanistic basis for this requirement has remained unclear. Here, cryo-EM structures and biochemical analyses show that centrally mismatched targets propagate along the nucleic acid–binding channel of bilobed AGO2, whereas centrally matched targets form a duplex that pries open the tapered channel, collapsing the bilobed architecture into a duplex-bound MID–PIWI lobe and an RNA-free N–PAZ lobe. This rearrangement generates a preactive open intermediate that accommodates the extensively paired duplex. The uncoupled N–PAZ lobe must then swing back and reassemble the bilobed architecture, thereby positioning the duplex in the PIWI catalytic center and promoting target cleavage.
- 10 August 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (33)
Open AccessCentral guide–target pairing activates human Argonaute2 by uncoupling the N-PAZ and MID–PIWI lobes
Small interfering RNAs (siRNAs) are widely used to repress gene expression. For human Argonaute2 (AGO2) to cleave target RNA, siRNAs must be almost perfectly complementary to their targets, particularly in the central region, yet the mechanistic basis for this requirement has remained unclear. Here, cryo-EM structures and biochemical analyses show that centrally mismatched targets propagate along the nucleic acid–binding channel of bilobed AGO2, whereas centrally matched targets form a duplex that pries open the tapered channel, collapsing the bilobed architecture into a duplex-bound MID–PIWI lobe and an RNA-free N–PAZ lobe. This rearrangement generates a preactive open intermediate that accommodates the extensively paired duplex. The uncoupled N–PAZ lobe must then swing back and reassemble the bilobed architecture, thereby positioning the duplex in the PIWI catalytic center and promoting target cleavage.
- Open Access
- 14 November 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (46)
Neurodevelopmental disorder–linked Argonaute mutations permit delayed RISC formation and unusual shortening of miRNAs by 3′→5′ trimming
Mutations in Argonaute proteins (AGOs) cause Argonaute syndrome, a neurodevelopmental disorder (NDD), yet the underlying molecular mechanism remains unclear. We determined cryo-electron microscopy (cryo-EM) structures of wild-type (WT) AGO1 and the recurrent, severe causative ΔF180 mutant. AGO1(ΔF180) unexpectedly rearranges the hydrophobic core of the L1 domain to preserve the overall RNA-induced silencing complexes (RISC) architecture and recognize guide RNAs similarly to WT. Functionally, the mutant binds target RNAs like WT but more frequently retains passenger strands, implicating a defect in RISC assembly. Biochemical assays of ΔF180 and L190P mutants revealed normal duplex loading but impaired passenger ejection, exposing guide 3′ ends to 3′→5′ exonucleases and generating abnormally short ~11-nucleotide RNAs. In cells, AGO1(ΔF180), AGO1(G199S), and corresponding AGO2 mutants likewise produced truncated guides. Together, these findings support a model in which defective passenger ejection underlies the pathology of AGO-associated NDDs by rendering microRNAs bound to AGO syndrome mutants susceptible to aberrant 3′ trimming.
- 14 November 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (46)
Open AccessNeurodevelopmental disorder–linked Argonaute mutations permit delayed RISC formation and unusual shortening of miRNAs by 3′→5′ trimming
Mutations in Argonaute proteins (AGOs) cause Argonaute syndrome, a neurodevelopmental disorder (NDD), yet the underlying molecular mechanism remains unclear. We determined cryo-electron microscopy (cryo-EM) structures of wild-type (WT) AGO1 and the recurrent, severe causative ΔF180 mutant. AGO1(ΔF180) unexpectedly rearranges the hydrophobic core of the L1 domain to preserve the overall RNA-induced silencing complexes (RISC) architecture and recognize guide RNAs similarly to WT. Functionally, the mutant binds target RNAs like WT but more frequently retains passenger strands, implicating a defect in RISC assembly. Biochemical assays of ΔF180 and L190P mutants revealed normal duplex loading but impaired passenger ejection, exposing guide 3′ ends to 3′→5′ exonucleases and generating abnormally short ~11-nucleotide RNAs. In cells, AGO1(ΔF180), AGO1(G199S), and corresponding AGO2 mutants likewise produced truncated guides. Together, these findings support a model in which defective passenger ejection underlies the pathology of AGO-associated NDDs by rendering microRNAs bound to AGO syndrome mutants susceptible to aberrant 3′ trimming.